Sudsakorn S, Bahadduri P, Fretland J, Lu C. 2020 FDA drug-drug interaction guidance: a comparison analysis and action plan by pharmaceutical industrial scientists. Curr Drug Metab. 2020;21(6):403–26.

Article  CAS  PubMed  Google Scholar 

Krichbaum M, Miransky N, Perez A. Trends in pain medication use in patients with type 2 diabetes: NHANES 2005–2018. J Pain Palliat Care Pharmacother. 2023;37(3):223–33.

Article  PubMed  Google Scholar 

Hau RK, Wright SH, Cherrington NJ. Addressing the clinical importance of equilibrative nucleoside transporters in drug discovery and development. Clin Pharmacol Ther. 2023;114(4):780–94.

Article  CAS  PubMed  Google Scholar 

Mease J, Ramamoorthy A, Yang X, Madabushi R, Pfuma FE, Zineh I. Statin drug-drug interactions: pharmacokinetic basis of FDA labeling recommendations and comparison across common tertiary clinical resources. J Clin Pharmacol. 2024;64(4):704–12.

Article  CAS  PubMed  Google Scholar 

Su YY, Chiang NJ, Chang JS, Wang YW, Shen BN, Li YJ, et al. The association between UGT1a1 polymorphisms and treatment toxicities of liposomal irinotecan. Esmo Open. 2023;8(1): 100746.

Article  PubMed  Google Scholar 

Alatwi E, Bairam A. The role of genetic polymorphisms in the sulfation of pregnenolone by human cytosolic sulfotransferase SULT2b1a. Res Sq. 2023;rs.3.rs-3471389.

Miao L, Wu F, Yang X, Mousa YM, Ramamoorthy A, Lee S, et al. Application of solubility and dissolution profile comparison for prediction of gastric Ph-mediated drug-drug interactions. AAPS J. 2022;24(1):35–35.

Article  CAS  PubMed  Google Scholar 

Wang CM, Fernez MT, Woolston BM, Carrier RL. Native gastrointestinal mucus: critical features and techniques for studying interactions with drugs, drug carriers, and bacteria. Adv Drug Deliv Rev. 2023;200: 114966.

Article  CAS  PubMed  Google Scholar 

Sun J, Li R, Zhang J, Huang Y, Lu Y, Liu C, et al. Analysis of compatibility mechanism of shenxiong glucose injection after multiple dosing based on differences of PK-PD correlation and cytochrome P450 enzyme. J Pharm Biomed Anal. 2024;239: 115899.

Article  CAS  PubMed  Google Scholar 

Zhang L, Xie H, Wang Y, Wang H, Hu J, Zhang G. Pharmacodynamic parameters of pharmacokinetic/pharmacodynamic (PK/PD) integration models. Front Vet Sci. 2022;9: 860472.

Article  PubMed  PubMed Central  Google Scholar 

Jang HY, Song J, Kim JH, Lee H, Kim IW, Moon B, et al. Machine learning-based quantitative prediction of drug exposure in drug-drug interactions using drug label information. NPJ Digit Med. 2022;5(1):88.

Article  PubMed  PubMed Central  Google Scholar 

Sall C, Argikar U, Fonseca K, Hilgendorf C, Lopes F, Riedel J, et al. Industry perspective on therapeutic peptide drug-drug interaction assessments during drug development: a European federation of pharmaceutical industries and associations white paper. Clin Pharmacol Ther. 2023;113(6):1199–216.

Article  CAS  PubMed  Google Scholar 

Shan Z, Yang X, Liu H, Yuan Y, Xiao Y, Nan J, et al. Cryo-EM structures of human organic anion transporting polypeptide OATP1b1. Cell Res. 2023;33(12):940–51.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Daniel WA, Bromek E, Danek PJ, Haduch A. The mechanisms of interactions of psychotropic drugs with liver and brain cytochrome P450 and their significance for drug effect and drug-drug interactions. Biochem Pharmacol. 2022;199: 115006.

Article  CAS  PubMed  Google Scholar 

Hu W, Zhang W, Zhou Y, Luo Y, Sun X, Xu H, et al. MECDDI: clarified drug–drug interaction mechanism facilitating rational drug use and potential drug–drug interaction prediction. J Chem Inf Model. 2023;63(5):1626–36.

Article  CAS  PubMed  Google Scholar 

Huang L, Chen Q, Lan W. Predicting drug-drug interactions based on multi-view and multichannel attention deep learning. Health Inf Sci Syst. 2023;11(1):50.

Article  PubMed  Google Scholar 

Wang L, Shendre A, Chiang CW, Cao W, Ning X, Zhang P, et al. A pharmacovigilance study of pharmacokinetic drug interactions using a translational informatics discovery approach. Br J Clin Pharmacol. 2022;88(4):1471–81.

Article  CAS  PubMed  Google Scholar 

Chu X, Prasad B, Neuhoff S, Yoshida K, Leeder JS, Mukherjee D, et al. Clinical implications of altered drug transporter abundance/function and PBPK modeling in specific populations: an ITC perspective. Clin Pharmacol Ther. 2022;112(3):501–26.

Article  CAS  PubMed  Google Scholar 

Shukkoor M, Baharuldin M, Raja K. A text mining protocol for extracting drug-drug interaction and adverse drug reactions specific to patient population, pharmacokinetics, pharmacodynamics, and disease. Methods Mol Biol. 2022;2496:259–82.

Article  CAS  PubMed  Google Scholar 

Colon OR, Knerler S, Fridman LB, Mercado A, Price AS, Rosado-Franco JJ, et al. Cocaine regulates antiretroviral therapy CNS access through pregnane-x receptor-mediated drug transporter and metabolizing enzyme modulation at the blood brain barrier. Fluids Barriers Cns. 2024;21(1):5.

Article  Google Scholar 

Budagaga Y, Sabet Z, Zhang Y, Novotna E, Hanke I, Rozkos T, et al. Tazemetostat synergistically combats multidrug resistance by the unique triple inhibition of ABCB1, ABCC1, and ABCG2 efflux transporters in vitro and ex vivo. Biochem Pharmacol. 2023;216: 115769.

Article  CAS  PubMed  Google Scholar 

Tseng E, Lin J, Strelevitz TJ, Dasilva E, Goosen TC, Obach RS. Projections of drug–drug interactions caused by time-dependent inhibitors of cytochrome P450 1a2, 2b6, 2c8, 2c9, 2c19, and 2d6 using in vitro data in static and dynamic models. Drug Metab Dispos. 2024;52(5):422–31.

Article  CAS  Google Scholar 

Gomez-Mantilla JD, Huang F, Peters SA. Can mechanistic static models for drug–drug interactions support regulatory filing for study waivers and label recommendations? Clin Pharmacokinet. 2023;62(3):457–80.

Article  PubMed  PubMed Central  Google Scholar 

Lai Y, Chu X, Di L, Gao W, Guo Y, Liu X, et al. Recent advances in the translation of drug metabolism and pharmacokinetics science for drug discovery and development. Acta Pharm Sin B. 2022;12(6):2751–77.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu S, Sodhi JK, Benet LZ. Analyzing potential intestinal transporter drug–drug interactions: reevaluating ticagrelor interaction studies. Pharm Res. 2021;38(10):1639–44.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sabo JP, Kort J, Ballow C, Haschke M, Battegay M, Fuhr R, et al. Clinical assessment of potential drug interactions of faldaprevir, a hepatitis c virus protease inhibitor, with darunavir/ritonavir, efavirenz, and tenofovir. Clin Infect Dis. 2014;59(10):1420–8.

Article  CAS  PubMed  Google Scholar 

Lu J, Zhang Y, Sun M, Liu M, Wang X. Comprehensive assessment of cucurbitacin e related hepatotoxicity and drug–drug interactions involving CYP3A and p-glycoprotein. Phytomedicine. 2017;26:1–10.

Article  CAS  PubMed  Google Scholar 

Yong WP, Desai AA, Innocenti F, Ramirez J, Shepard D, Kobayashi K, et al. Pharmacokinetic modulation of oral etoposide by ketoconazole in patients with advanced cancer. Cancer Chemother Pharmacol. 2007;60(6):811–9.

Article  CAS  PubMed  Google Scholar 

Courlet P, Guidi M, Alves SS, Cavassini M, Stoeckle M, Buclin T, et al. Population pharmacokinetic modelling to quantify the magnitude of drug–drug interactions between amlodipine and antiretroviral drugs. Eur J Clin Pharmacol. 2021;77(7):979–87.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bechtold BJ, Lynch KD, Oyanna VO, Call MR, Graf TN, Oberlies NH, et al. Rifampin- and silymarin-mediated pharmacokinetic interactions of exogenous and endogenous substrates in a transgenic OATP1b mouse model. Mol Pharm. 2024;21(5):2284–97.

Article  CAS  PubMed  Google Scholar